Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria

Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:African health sciences 2007-09, Vol.7 (3), p.143-147
Hauptverfasser: Aboderin, Oladiipo A, Abdu, Abdul R, Odetoyin, Babatunde 'Wumi, Okeke, Iruka N, Lawa, Oladejo O, Ndububa, Dennis A, Agbakwuru, Augustine E, Lamikanra, Adebayo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 147
container_issue 3
container_start_page 143
container_title African health sciences
container_volume 7
creator Aboderin, Oladiipo A
Abdu, Abdul R
Odetoyin, Babatunde 'Wumi
Okeke, Iruka N
Lawa, Oladejo O
Ndububa, Dennis A
Agbakwuru, Augustine E
Lamikanra, Adebayo
description Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H. pylori in Ile-Ife, South-West Nigeria. In one collaborative study, we detected H. pylori in 195 (73%) patients referred for endoscopy at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC). Furthermore we have observed a variegated gastric inflammatory response and atrophy including atrophic pangastritis but are yet to demonstrate MALToma in any of our patients. In addition we have demonstrated that dental plaque is a possible source of gastric H. pylori infection and such an endogenous source could account for difficulty in eradication leading to re-infection. Presently, infected patients are treated with standard combination therapy made up of amoxycilin and ciprofloxacin with a proton pump inhibitor/bismuth. Reports however have shown that the incidence of antimicrobial resistance in Helicobacter pylori is a growing problem and which has been linked with failures in treatment and eradication. Given this situation it has become necessary to have information about the susceptibility of isolates to particular antimicrobial agents before the selection of an appropriate treatment regimen. More recently, we sought to study antimicrobial susceptibility of locally isolated H. pylori strains. We subjected 32 isolates to antimicrobial susceptibility testing against seven agents. All the isolates showed multiple acquired antimicrobial resistance as they were all resistant to amoxicillin, clarithromycin, metronidazole, while 29/31, 27/31 showed resistance to rifampicin and tetracycline respectively. Five (15.6%) of these isolates showed resistance to ciprofloxacin. Our findings suggest that H. pylori strains isolated within our study environment have acquired resistance to all the commonly prescribed antibiotics. On the basis of the findings it would be necessary to re-evaluate the eradication treatment regime in our setting.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2269713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2586791087</sourcerecordid><originalsourceid>FETCH-LOGICAL-b246t-fbaad5529c783b428eca158951546ddbc00f770626f37a358e8dfb97c265058b3</originalsourceid><addsrcrecordid>eNpdkFtLwzAYhosoOqd_QQKCV6sk6XK6EWSoG4iKhxtvQpKmW0bbaJIq-_cGPKBCIOHLw8v7PVvFCDEsSkhgtZ3flMOSCkj2iv0Y1xBiigTaLfYQhwRzykbF83mfnHY-OQPubXQxqd5Y4Bswt60zXiuTbAB3m9YHB5rgO3CnkrN9isD1YNHactHYCXjwQ1qV7zamCbhxSxucOih2GtVGe_h1j4uny4vH2by8vr1azM6vS42nNJWNVqomBAvDeKWnmFujEOGCIDKlda0NhA1jkGLaVExVhFteN1owgymBhOtqXJx95r4MurO1yd2CauVLcJ0KG-mVk39_ereSS_8mMaaCoSoHnHwFBP865BVk56Kxbat664cos0FEaEUzePwPXPsh9Hk5iUnWKRDkLFNHv_v8FPmWnoHTTyB7b11vfwiTrcnv4SrmAxnEovoAsbGQBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586791087</pqid></control><display><type>article</type><title>Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>African Journals Online (Open Access)</source><source>Bioline International</source><source>PubMed Central</source><creator>Aboderin, Oladiipo A ; Abdu, Abdul R ; Odetoyin, Babatunde 'Wumi ; Okeke, Iruka N ; Lawa, Oladejo O ; Ndububa, Dennis A ; Agbakwuru, Augustine E ; Lamikanra, Adebayo</creator><creatorcontrib>Aboderin, Oladiipo A ; Abdu, Abdul R ; Odetoyin, Babatunde 'Wumi ; Okeke, Iruka N ; Lawa, Oladejo O ; Ndububa, Dennis A ; Agbakwuru, Augustine E ; Lamikanra, Adebayo</creatorcontrib><description>Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H. pylori in Ile-Ife, South-West Nigeria. In one collaborative study, we detected H. pylori in 195 (73%) patients referred for endoscopy at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC). Furthermore we have observed a variegated gastric inflammatory response and atrophy including atrophic pangastritis but are yet to demonstrate MALToma in any of our patients. In addition we have demonstrated that dental plaque is a possible source of gastric H. pylori infection and such an endogenous source could account for difficulty in eradication leading to re-infection. Presently, infected patients are treated with standard combination therapy made up of amoxycilin and ciprofloxacin with a proton pump inhibitor/bismuth. Reports however have shown that the incidence of antimicrobial resistance in Helicobacter pylori is a growing problem and which has been linked with failures in treatment and eradication. Given this situation it has become necessary to have information about the susceptibility of isolates to particular antimicrobial agents before the selection of an appropriate treatment regimen. More recently, we sought to study antimicrobial susceptibility of locally isolated H. pylori strains. We subjected 32 isolates to antimicrobial susceptibility testing against seven agents. All the isolates showed multiple acquired antimicrobial resistance as they were all resistant to amoxicillin, clarithromycin, metronidazole, while 29/31, 27/31 showed resistance to rifampicin and tetracycline respectively. Five (15.6%) of these isolates showed resistance to ciprofloxacin. Our findings suggest that H. pylori strains isolated within our study environment have acquired resistance to all the commonly prescribed antibiotics. On the basis of the findings it would be necessary to re-evaluate the eradication treatment regime in our setting.</description><identifier>ISSN: 1680-6905</identifier><identifier>EISSN: 1729-0503</identifier><identifier>PMID: 18052867</identifier><language>eng</language><publisher>Uganda: Makerere University Medical School</publisher><subject>Adult ; Aged ; Anti-Bacterial Agents - therapeutic use ; Biopsy ; Drug Resistance, Bacterial ; Female ; Helicobacter pylori - drug effects ; Helicobacter pylori - isolation &amp; purification ; Humans ; Male ; Middle Aged ; Nigeria ; Original</subject><ispartof>African health sciences, 2007-09, Vol.7 (3), p.143-147</ispartof><rights>Copyright 2007 - Makerere Medical School, Uganda</rights><rights>Copyright © Makerere Medical School, Uganda 2007 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2269713/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2269713/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793,79426</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18052867$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aboderin, Oladiipo A</creatorcontrib><creatorcontrib>Abdu, Abdul R</creatorcontrib><creatorcontrib>Odetoyin, Babatunde 'Wumi</creatorcontrib><creatorcontrib>Okeke, Iruka N</creatorcontrib><creatorcontrib>Lawa, Oladejo O</creatorcontrib><creatorcontrib>Ndububa, Dennis A</creatorcontrib><creatorcontrib>Agbakwuru, Augustine E</creatorcontrib><creatorcontrib>Lamikanra, Adebayo</creatorcontrib><title>Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria</title><title>African health sciences</title><addtitle>Afr Health Sci</addtitle><description>Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H. pylori in Ile-Ife, South-West Nigeria. In one collaborative study, we detected H. pylori in 195 (73%) patients referred for endoscopy at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC). Furthermore we have observed a variegated gastric inflammatory response and atrophy including atrophic pangastritis but are yet to demonstrate MALToma in any of our patients. In addition we have demonstrated that dental plaque is a possible source of gastric H. pylori infection and such an endogenous source could account for difficulty in eradication leading to re-infection. Presently, infected patients are treated with standard combination therapy made up of amoxycilin and ciprofloxacin with a proton pump inhibitor/bismuth. Reports however have shown that the incidence of antimicrobial resistance in Helicobacter pylori is a growing problem and which has been linked with failures in treatment and eradication. Given this situation it has become necessary to have information about the susceptibility of isolates to particular antimicrobial agents before the selection of an appropriate treatment regimen. More recently, we sought to study antimicrobial susceptibility of locally isolated H. pylori strains. We subjected 32 isolates to antimicrobial susceptibility testing against seven agents. All the isolates showed multiple acquired antimicrobial resistance as they were all resistant to amoxicillin, clarithromycin, metronidazole, while 29/31, 27/31 showed resistance to rifampicin and tetracycline respectively. Five (15.6%) of these isolates showed resistance to ciprofloxacin. Our findings suggest that H. pylori strains isolated within our study environment have acquired resistance to all the commonly prescribed antibiotics. On the basis of the findings it would be necessary to re-evaluate the eradication treatment regime in our setting.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Biopsy</subject><subject>Drug Resistance, Bacterial</subject><subject>Female</subject><subject>Helicobacter pylori - drug effects</subject><subject>Helicobacter pylori - isolation &amp; purification</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nigeria</subject><subject>Original</subject><issn>1680-6905</issn><issn>1729-0503</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>RBI</sourceid><sourceid>EIF</sourceid><recordid>eNpdkFtLwzAYhosoOqd_QQKCV6sk6XK6EWSoG4iKhxtvQpKmW0bbaJIq-_cGPKBCIOHLw8v7PVvFCDEsSkhgtZ3flMOSCkj2iv0Y1xBiigTaLfYQhwRzykbF83mfnHY-OQPubXQxqd5Y4Bswt60zXiuTbAB3m9YHB5rgO3CnkrN9isD1YNHactHYCXjwQ1qV7zamCbhxSxucOih2GtVGe_h1j4uny4vH2by8vr1azM6vS42nNJWNVqomBAvDeKWnmFujEOGCIDKlda0NhA1jkGLaVExVhFteN1owgymBhOtqXJx95r4MurO1yd2CauVLcJ0KG-mVk39_ereSS_8mMaaCoSoHnHwFBP865BVk56Kxbat664cos0FEaEUzePwPXPsh9Hk5iUnWKRDkLFNHv_v8FPmWnoHTTyB7b11vfwiTrcnv4SrmAxnEovoAsbGQBw</recordid><startdate>200709</startdate><enddate>200709</enddate><creator>Aboderin, Oladiipo A</creator><creator>Abdu, Abdul R</creator><creator>Odetoyin, Babatunde 'Wumi</creator><creator>Okeke, Iruka N</creator><creator>Lawa, Oladejo O</creator><creator>Ndububa, Dennis A</creator><creator>Agbakwuru, Augustine E</creator><creator>Lamikanra, Adebayo</creator><general>Makerere University Medical School</general><general>Makerere Medical School</general><scope>RBI</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200709</creationdate><title>Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria</title><author>Aboderin, Oladiipo A ; Abdu, Abdul R ; Odetoyin, Babatunde 'Wumi ; Okeke, Iruka N ; Lawa, Oladejo O ; Ndububa, Dennis A ; Agbakwuru, Augustine E ; Lamikanra, Adebayo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b246t-fbaad5529c783b428eca158951546ddbc00f770626f37a358e8dfb97c265058b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Biopsy</topic><topic>Drug Resistance, Bacterial</topic><topic>Female</topic><topic>Helicobacter pylori - drug effects</topic><topic>Helicobacter pylori - isolation &amp; purification</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nigeria</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aboderin, Oladiipo A</creatorcontrib><creatorcontrib>Abdu, Abdul R</creatorcontrib><creatorcontrib>Odetoyin, Babatunde 'Wumi</creatorcontrib><creatorcontrib>Okeke, Iruka N</creatorcontrib><creatorcontrib>Lawa, Oladejo O</creatorcontrib><creatorcontrib>Ndububa, Dennis A</creatorcontrib><creatorcontrib>Agbakwuru, Augustine E</creatorcontrib><creatorcontrib>Lamikanra, Adebayo</creatorcontrib><collection>Bioline International</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>African health sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aboderin, Oladiipo A</au><au>Abdu, Abdul R</au><au>Odetoyin, Babatunde 'Wumi</au><au>Okeke, Iruka N</au><au>Lawa, Oladejo O</au><au>Ndububa, Dennis A</au><au>Agbakwuru, Augustine E</au><au>Lamikanra, Adebayo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria</atitle><jtitle>African health sciences</jtitle><addtitle>Afr Health Sci</addtitle><date>2007-09</date><risdate>2007</risdate><volume>7</volume><issue>3</issue><spage>143</spage><epage>147</epage><pages>143-147</pages><issn>1680-6905</issn><eissn>1729-0503</eissn><abstract>Helicobacter pylori has become recognized as a major cause of gastroduodenal diseases in man. Evidence indicates that once acquired, H. pylori persists, usually for life unless eradicated by antimicrobial therapy. Over the past few years, we have accumulated some knowledge of the epidemiology of H. pylori in Ile-Ife, South-West Nigeria. In one collaborative study, we detected H. pylori in 195 (73%) patients referred for endoscopy at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC). Furthermore we have observed a variegated gastric inflammatory response and atrophy including atrophic pangastritis but are yet to demonstrate MALToma in any of our patients. In addition we have demonstrated that dental plaque is a possible source of gastric H. pylori infection and such an endogenous source could account for difficulty in eradication leading to re-infection. Presently, infected patients are treated with standard combination therapy made up of amoxycilin and ciprofloxacin with a proton pump inhibitor/bismuth. Reports however have shown that the incidence of antimicrobial resistance in Helicobacter pylori is a growing problem and which has been linked with failures in treatment and eradication. Given this situation it has become necessary to have information about the susceptibility of isolates to particular antimicrobial agents before the selection of an appropriate treatment regimen. More recently, we sought to study antimicrobial susceptibility of locally isolated H. pylori strains. We subjected 32 isolates to antimicrobial susceptibility testing against seven agents. All the isolates showed multiple acquired antimicrobial resistance as they were all resistant to amoxicillin, clarithromycin, metronidazole, while 29/31, 27/31 showed resistance to rifampicin and tetracycline respectively. Five (15.6%) of these isolates showed resistance to ciprofloxacin. Our findings suggest that H. pylori strains isolated within our study environment have acquired resistance to all the commonly prescribed antibiotics. On the basis of the findings it would be necessary to re-evaluate the eradication treatment regime in our setting.</abstract><cop>Uganda</cop><pub>Makerere University Medical School</pub><pmid>18052867</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1680-6905
ispartof African health sciences, 2007-09, Vol.7 (3), p.143-147
issn 1680-6905
1729-0503
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2269713
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; African Journals Online (Open Access); Bioline International; PubMed Central
subjects Adult
Aged
Anti-Bacterial Agents - therapeutic use
Biopsy
Drug Resistance, Bacterial
Female
Helicobacter pylori - drug effects
Helicobacter pylori - isolation & purification
Humans
Male
Middle Aged
Nigeria
Original
title Antibiotic Resistance of Helicobacter Pylori from Patients in Ile-Ife, South-west, Nigeria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A13%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20Resistance%20of%20Helicobacter%20Pylori%20from%20Patients%20in%20Ile-Ife,%20South-west,%20Nigeria&rft.jtitle=African%20health%20sciences&rft.au=Aboderin,%20Oladiipo%20A&rft.date=2007-09&rft.volume=7&rft.issue=3&rft.spage=143&rft.epage=147&rft.pages=143-147&rft.issn=1680-6905&rft.eissn=1729-0503&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2586791087%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2586791087&rft_id=info:pmid/18052867&rfr_iscdi=true